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Abstract 
The functional link between zinc homeostasis and membrane-related processes, including lipid 
metabolism regulation, extends from yeast to humans, and has a likely role in the pathogenesis of 
diabetes. The yeast Izh2 protein has been previously implicated in zinc ion homeostasis and in the 
regulation of lipid and phosphate metabolism, but its precise molecular function is not known. We 
performed a chemogenomics experiment to determine the genes conferring resistance or sensitivity to 
different environmental zinc concentrations. We then determined under normal, depleted and excess 
zinc concentrations, the genetic interactions of IZH2 on the genome-wide level and measured changes in 
the transcriptome caused by deletion of IZH2. We found evidence for an important cellular function of 
the Rim101 pathway in zinc homeostasis in neutral or acidic environments, and observed that 
phosphatidylinositol is a source of inositol when zinc availability is limited. Comparison of our 
experimental profiles with published gene expression and genetic interaction profiles revealed 
pleiotropic functions for Izh2. We propose that Izh2 acts as an integrator of intra- and extracellular 
signals in providing adequate cellular responses to maintain homeostasis under different external 
conditions, including – but not limited to – alterations in zinc concentrations. 
 
Introduction 
Zinc is one of the essential nutrients necessary for sustaining life. Its overload in an organism is, 
however, toxic. Cells must therefore possess homeostatic mechanisms to ensure that intracellular zinc 
concentrations stay within the physiological limits, otherwise their growth and development are 
impaired1. The main mechanism for maintaining an appropriate intracellular zinc concentration in yeast 
Saccharomyces cerevisiae cells is its import via plasma membrane transporters (Zrt1/2, as well as Fet4 
and Pho84 proteins) and its interchange between the cytosol and the vacuole, which is where excess 
zinc is predominantly stored in this organism2, via vacuolar membrane transporters (Zrt3, Cot1 and Zrc1 
proteins). Zinc is a structural or catalytic co-factor of many proteins and it is estimated that more than 
10% of the proteins encoded in the human genome require zinc for their activity, zinc-finger proteins 
being the most abundant class among them3. Moreover, class I, II and IV histone deacetylases (HDACs) 
are Zn-dependent4, indicating that changes in Zn concentrations exert significant effects on the 
expression levels of a subset of genes5. It has been furthermore suggested that the essential function of 
zinc is its antioxidant activity, which, among other effects on cellular processes, stabilizes cellular 
membranes6. 
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The effect of zinc on membrane homeostasis occurs also through modulation of phospholipid 
metabolism. Zinc depletion in S. cerevisiae activates the Zap1 transcriptional activator, among whose 
target genes are PIS1, encoding phosphatidylinositol synthase, and DPP1, encoding diacylglycerol 
pyrophosphate phosphatase. Zn depletion thus causes an increase in phosphatidylinositol 
concentrations and a decrease in phosphatidylethanolamine concentrations7, 8. In addition, zinc 
depletion causes a decrease in the concentration of phosphatidic acid, thus triggering the release of 
Opi1 from the ER membrane and its translocation into the nucleus, where it represses expression of 
CHO1, encoding phosphatidylserine synthase, and INO1, encoding inositol-3-phosphate synthase, by 
inhibitory binding to Ino2/4 complex7. 
In humans, zinc depletion can lead to insulin production and secretion disorders, while hyperglycemia 
results in increased secretion and a concomitant decrease in total body zinc9. The connection between 
diabetes and zinc is complex and a clear cause and effect relationship is still unknown9, 10. One 
mechanism by which zinc affects metabolism and diabetes is the structural role of zinc in the formation 
of the insulin hexamer, the storage form of the hormone. Therefore, zinc is important for synthesis, 
storage, proper conformation and excretion of insulin from pancreatic β-cells11. Adiponectin is another 
polypeptide hormone that regulates metabolism in humans, and its deficiency is one of the main causes, 
defined on the molecular level, for insulin resistance, type 2 diabetes, and metabolic syndrome12, 13. Two 
adiponectin receptors from the progesterone-adiponectin receptor family (PAQR), AdipoR1 and 
AdipoR2, are known in humans and they have been shown to mediate the antidiabetic metabolic actions 
of adiponectin14. In yeast, structural adiponectin receptor homologues are encoded by IZH1/2/3/4 
(Implicated in Zinc Homeostasis) genes, deletions of which exert zinc-dependent mutant phenotypes 
and are, with the exception of IZH3, regulated by Zap1/zinc levels, as well as by the fatty acid-activated 
Oaf1/Pip2 transcription factors15, 16. IZH2 and especially IZH4 expression has been shown to be regulated 
also by Mga216, a transcriptional activator that in response to hypoxia induces expression of genes such 
as OLE117, which encodes the sole fatty acid desaturase in yeast. Izh2 is localized to the plasma 
membrane and is a putative functional homologue of adiponectin receptors since it binds osmotin, a 
plant homolog of adiponectin18. In addition, heterologous expression of human adiponectin receptors in 
yeast results in functional complementation of Izh2 in ion homeostasis, and their activation with 
adiponectin elicits a signaling cascade that includes the same signaling proteins as Izh2p overexpression, 
such as AMPK/Snf119. Cells lacking Izh2 are resistant to the ergosterol-binding polyene antifungal 
compound nystatin15 which provokes a transcriptional response similar to zinc depletion20. Based on 
these results, Izh2 was proposed to affect the sterol composition and consequently the permeability of 
cellular membranes16. Moreover, the transcriptional response to polyene antifungal compounds 
includes an increase in the expression of genes from the PHO pathway, which contributes to increased 
levels of free intracellular phosphate. These same genes were found to have increased expression in 
izh2Δ cells, suggesting a role for Izh2 also in the regulation of phosphate metabolism15. How these 
processes are linked through the molecular function of Izh2 is not well understood. However, it has 
been proposed that Izh2 is involved in a signal transduction cascade, which could be either zinc-
mediated or independent of zinc16. To address these questions, we compared the effects of zinc 
depletion or overload and the absence of Izh2 protein in yeast on a genome-wide level. 
 
Results 
Chemogenetic interactions of zinc depletion and overload 
In order to obtain a broad and genome-wide insight into the effects of zinc depletion and overload on 
yeast cells, we first performed chemogenomic analysis to identify single gene deletion strains that are 
sensitive or resistant, compared to the reference strain, to altered zinc concentrations21. For zinc 
depletion conditions, 50 nM ZnCl2 was selected based on the semi-inhibitory effect of this concentration 
on the growth of the reference strain. Zinc overload conditions were achieved using 4 mM ZnCl2, and 10 
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µM zinc was used for the control media, which is within the range found to be optimal for yeast cells22. 
The collected results are shown in Supplementary Table 1. 
Three deletion strains were found to be significantly sensitive to zinc depletion. As expected, cells 
lacking the ZRT1 gene, which encodes the high-affinity zinc transporter and is responsible for the 
majority of zinc uptake23, were sensitive to zinc depletion. Additionally, the strain lacking the ADH4 
gene, coding for the zinc-dependent alcohol dehydrogenase isoenzyme, and the strain lacking the TSA1 
gene, encoding thioredoxin peroxidase, were found to be sensitive. Expression of ZRT1, ADH4 and TSA1 
has been found to be induced in response to zinc deficiency by the Zap1 transcription factor, and zrt1Δ, 
adh4Δ and tsa1Δ strains have previously been identified as being sensitive to zinc deficiency23-27. These 
results thus provided a positive control for the zinc depletion conditions employed here, and suggested 
that Zap1 is the major regulator of the genes identified in the screening. 
Interestingly, under conditions of zinc depletion, we identified more resistant than sensitive strains: 27 
significantly resistant strains, of which 22 highly significant, were identified (Supplementary Table 1). 
Two mutants have known defects in ion homeostasis, vph1Δ and mmt2Δ; Vph1 is the subunit a of the 
vacuolar ATPase (V-ATPase) V0 domain, and Mmt2 is a putative metal transporter
28, 29. Three of the 
resistant strains had deletions of genes which participate in lipid metabolism or membrane biology-
related processes: CEM1, encoding a beta-keto-acyl synthase with potential role in fatty acid synthesis in 
mitochondria30, 31, ATG2, coding for a membrane protein required for vesicle formation during 
autophagy and pexophagy32, 33, and INO1, an essential gene in environments lacking inositol, coding for 
inositol-3-phosphate synthase, the rate limiting enzyme for the synthesis of inositol and consequently 
for inositol-containing phospholipids34, 35. Interestingly from the perspective of zinc deficiency-related 
oxidative stress, the strain without the TRR2 gene, coding for mitochondrial thioredoxin reductase, was 
found to be resistant to zinc depletion. 
In the screening with high zinc concentrations (zinc overload), 161 strains were found to be significantly 
sensitive (Supplementary Table 1). As expected, the zrc1Δ strain lacking the transporter responsible for 
zinc uptake into vacuoles22 was identified in this screening: the role of Zrc1 is to prevent acute 
accumulation of cytosolic zinc36. Also expected was a highly enriched group of genes annotated to 
vesicle-mediated transport (p-value=3.34e-12; http://go.princeton.edu/cgi-bin/GOTermFinder), which is 
a general indicator of cellular stress37. The strain lacking Vph1 was found to be sensitive to excess zinc – 
this same strain was resistant to depleted zinc (see above), suggesting that deletion of VPH1 gene 
results in increased cytosolic zinc concentrations under conditions of both elevated and decreased 
environmental zinc concentrations. This is in agreement with the finding that V-ATPase activity is 
required for vacuolar zinc sequestration38. Another deletion strain, ypr170cΔ, was found to be both 
resistant to zinc depletion and sensitive to excess zinc. YPR170C is a dubious open reading frame which 
does not overlap any known protein coding sequence, but whose mutation leads to significantly altered 
phenotypes, including resistance to ZnCl2 and to V-ATPase inhibitor concanamycin A
39. The similarity 
between the sets of strains resistant to zinc depletion and sensitive to zinc overload extended to genes 
involved in autophagy and in maintenance of cellular integrity: while deletion of ATG2, which results in 
resistance to zinc depletion (see above) was not found to also cause sensitivity to excess zinc, a number 
of other genes involved in autophagy were found in this screening – ATG21, CCZ1, MON1, TRS85, UTH1, 
VAM3, VAM6, VAM7, VPS41, VTC1, VTC4 and YPT7. The majority of these genes is also involved in 
membrane invagination. These two biological process ontology classes were among the enriched ones 
(p-value=1.8e-4 for membrane invagination and p-value=2.29e-3 for autophagy) among the hits 
sensitive to excess zinc. Deletion of the MGA2 gene, encoding the ER membrane-bound protein involved 
in the activation of the expression of OLE1 transcription (see above), also resulted in increased 
sensitivity to zinc overload. 
Ninety-seven strains were found to be resistant to excess zinc relative to wild-type growth 
(Supplementary Table 1). No overlap was found with the strains sensitive to zinc depletion, indicating 
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that no single gene deletion results in permanently lower intracellular zinc concentrations. Two strains, 
slm3Δ and yll056cΔ, were however identified as resistant to both high and low zinc concentrations. 
SLM3 encodes a mitochondrially-localized tRNA-specific 2-thiouridylase40, and YLL056C is co-expressed 
with genes involved in pleiotropic drug resistance41. Further research is necessary to elucidate the 
molecular mechanism behind the observed phenotypes, e.g. to establish whether the Yll056c protein is 
involved in zinc transmembrane transport. Strains with deletions of 5 genes, CTI6, DEP1, RXT2, SIN3 and 
UME1, encoding components of Rpd3L histone deacetylase complex, were found in the excess zinc-
resistant group as well. The Rpd3L complex represses transcription of its target genes through the 
activity of the Rpd3 deacetylase. In this group is also the dep1Δ strain that had the highest observed 
relative resistance. Importantly, the dep1Δ mutant has previously been found to be unable to regulate 
expression of INO1 and CHO1 genes42. Also, Sin3 has been previously shown to regulate the expression 
of OPI1 gene43, whose product regulates expression of INO1 and CHO1 (see above). 
The next group of functionally related genes whose deletions resulted in increased resistance to zinc 
overload consists of DFG16, RIM9, RIM20 and RIM101. These genes code for key components of the 
Rim101 pathway which is important for the adaptation of cells to alkaline pH44. One additional gene 
whose mutation led to resistance to excess zinc, YGR122W, has been implicated in Rim101 activation45. 
Since additional genes encode factors important for the Rim101 pathway46, we decided to determine 
the relative sensitivity to excess zinc of single deletion mutants of all known components of the pathway 
(Table 1). Phenotypes of the mutants identified in the screening were confirmed, and additionally 
deletions of genes VPS28, RIM8, RIM13, RIM21 and SNF7 were shown to confer resistance to excess zinc 
as well. Therefore, genetic perturbations of all components involved in the signal transduction from the 
plasma membrane to the endosome at high pH47 were shown to result in resistance to zinc overload. 
 
Combinatorial effects of pH, excess zinc and Rim101 pathway inhibitions 
To elucidate in more detail how cellular responses to high pH and elevated zinc concentrations are 
connected, we determined growth rates under conditions of different pH and elevated zinc levels, in the 
reference strain and in strains lacking RIM101, encoding the transcription factor that represents the last 
step of the Rim101 signaling pathway48, RIM20, encoding the activator of Rim101 protein49, or RIM9, 
encoding a protein functioning at the early/detection step of this signaling pathway50 (Figure 1A-C). Cells 
were grown in liquid media at pH 4 or 6 (higher pH values could not be used due to zinc precipitation), 
and with either 2.5 µM zinc (control concentration), or supplemented with 2 mM or 4 mM zinc (zinc 
overload). This experiment showed that the reference strain is more resistant to elevated zinc at higher 
pH, as the cells grew significantly better in the presence of 2 mM zinc at pH 6 than at pH 4. Deletion of 
any of the three RIM genes tested increased the resistance to zinc at pH 6, but even more significantly at 
pH 4. A similar, although significantly less pronounced effect was also observed in the zap1Δ strain 
(Figure 1D). These results suggest that cellular responses triggered by the Rim101 pathway have a 
negative effect on the adaptation to elevated zinc. 
 
Genetic interactions of IZH2 
Synthetic genetic array technology51 was used to generate double deletion mutant strains in the izh2Δ 
background. Genetic interactions of IZH2 were then determined in the presence of decreased, normal 
and increased zinc concentrations (Supplementary Table 2). Altogether, 204 genes showed a negative 
genetic interaction with IZH2 (Figure 2A). Of these, 5 genes were found under all three conditions, while 
an additional 16 were identified as interactors under two conditions (Supplementary Table 2). We could 
not find any clear functional links between these genes. The remaining genes were found only under a 
single condition. 
Thirty-two genes found to genetically interact with IZH2 code for proteins that are localized to 
membranes. Products of eight of them (AAC1, BAP3, BOR1, MEP1, MIR1, MRS2, STV1 and TIM18), exert 
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transmembrane transport activity; interestingly, five are mitochondrial. Stv1 is one of the two isoforms 
of the subunit a of the V-ATPase V0 domain
52; the other isoform is Vph1, and the vph1Δ strain was found 
to be sensitive to excess zinc and resistant to depleted zinc (see above). In addition, RAV1 was found to 
genetically interact with IZH2; Rav1 promotes assembly of the V-ATPase holoenzyme53, 54. These results 
are in agreement with the finding that izh2Δ strain is sensitive to elevated zinc concentrations16, 55, a 
condition that requires vacuolar zinc sequestration. Previous studies55, 56 have identified 11 genes which 
show a negative genetic interaction with IZH2. Two of these, ENV9 and EOS1, were also found in our 
study, and Env9 has also been found to be involved in vacuolar functions57. On the other hand, Izh2 was 
shown to suppress the hydrogen peroxide-sensitive EOS1 mutation, indicating a role for Izh2 in oxidative 
stress response55. Gene Ontology annotation enrichment analysis did not identify any significantly 
(p<0.01) enriched functional classes in the set of genes which interact genetically with IZH2, and the 
most enriched biological process was ‘regulation of RNA metabolic process’ (p-value=0.052). 
Comparison of the genetic interactions and the zinc depletion/overload chemogenomics screening 
showed that 25 genes display both genetic interaction with IZH2 and significantly altered 
sensitivity/resistance to zinc (Figure 2B). This number is higher than expected by chance only (p-value= 
0.00115). The group of 15 genes which show a negative genetic interaction with IZH2 and whose 
deletion strains are at the same time sensitive to excess zinc is enriched for genes involved in vacuolar 
transport, as it includes VPS9, VPS55 and VTC1. Two of these genes were found to genetically interact 
with IZH2 specifically at elevated zinc: VPS55, a late endosomal protein and a functional homolog of 
human leptin receptor overlapping transcript protein (LEPTOR)58, and VTC1, a subunit of the vacuolar 
transporter chaperone complex which is also involved in vacuolar polyphosphate accumulation and has 
mRNA binding activity59-61. In the group of 9 genes in negative genetic interaction with IZH2 whose 
deletion strains are at the same time resistant to excess zinc there are several genes that regulate 
cellular physiology. Genes encoding proteins involved in chromatin modification, UME1 and IOC4, as 
well as the SKN7 gene, encoding a transcription factor, were found to genetically interact with IZH2 
under conditions of zinc deficiency, whereas genes encoding two other transcription 
factors/transcriptional regulators (Xbp1 and Tos9), and two protein kinases (Ptk2 and Sak1) were found 
to be in genetic interaction with IZH2 at normal zinc concentrations. These differences imply that Izh2 
has multiple roles in the cell under different environmental zinc concentrations. 
 
Effect of IZH2 deletion on gene expression 
To further analyze the role of Izh2 in yeast cells, we compared gene expression in izh2Δ and reference 
strains, under conditions of normal (10 μM) and limiting (50 nm) zinc concentrations. To assess the role 
of Izh2 globally, results from normal and limiting zinc were combined to minimize the effect of 
environmental conditions and to increase statistical significance. To investigate the specific function of 
Izh2 under different conditions, the results were analyzed separately, but these results are statistically 
less robust. The expression results are presented in Supplementary Table 3 and available from the 
ArrayExpress database under the accession number E-MEXP-3995. 
First, we were interested in genes with decreased expression in izh2Δ cells under any condition, since 
this group should contain genes whose expression is potentially activated by Izh2. The most significantly 
down-regulated gene was VEL1, encoding a protein with unknown function. VEL1 has been identified as 
a gene with highly induced expression in zinc-depleted conditions in a Zap1-dependent manner62. Also in 
our experiments the decrease in expression was more pronounced at low zinc concentrations, 
suggesting that besides Zap1, Izh2 is required for the induction of VEL1 expression. The physiological 
role of this effect is however currently not known. To gain insight into the physiological consequences of 
IZH2 deletion, we performed functional enrichment analysis (http://go.princeton.edu/cgi-
bin/GOTermFinder) on genes with decreased expression in izh2Δ cells (Supplementary Table 3, p<0.01). 
The most significantly enriched were processes related to iron homeostasis (e.g. biological process ‘iron 
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chelate transport’ with the p-value=5.7 × 10-4) and included genes FIT1, FIT2, FIT3, encoding 
glycosylphosphatidylinositol (GPI)-anchored mannoproteins involved in the retention of siderophore-
iron in the cell wall63, FET4, encoding an importer for iron, zinc and copper, and MCD4, encoding an 
evolutionarily conserved protein involved in GPI anchor biosynthesis. We also specifically looked at 
genes involved in lipid metabolism and found several with decreased expression in izh2Δ cells: INO1, 
CHO1, TSC10 (encoding 3-ketosphinganine reductase, an essential enzyme in phytosphingosine 
synthesis), ERG28 (encoding an ER membrane protein involved in ergosterol biosynthesis), APQ12 (a 
gene with synthetic lethal genetic interactions with genes involved in lipid metabolism, encoding for a 
protein required for nuclear envelope morphology), and, again, MCD4. Among the genes with decreased 
expression in izh2Δ cells was also CLN3, encoding a G1 cyclin which, unlike other cyclins, is not regulated 
by the cell cycle, but is instead under the control of nutrient repletion by acetyl-CoA-mediated 
chromatin modification64. One of the few genes with decreased expression in izh2Δ cells under normal 
zinc conditions only was ZRT1. 
In the group of genes with induced expression in izh2Δ cells, the most significantly enriched group 
contained genes involved in polyphosphate metabolism or phosphate transport (e.g. biological 
processes ‘polyphosphate metabolic process’ with the p-value=1.3 × 10-5, ‘phosphate ion transport’ with 
the p-value=3.9 × 10-4 and ‘phosphorus metabolic process’ with the p-value=4.3 × 10-4). In this group are 
genes encoding acid phosphatases (PHO3, PHO5, PHO11 and PHO12) and phosphate transporters 
(PHO84, PHO89 and PIC2), as well as SPL2, encoding a protein similar to cyclin-dependent kinase 
inhibitors that negatively regulates low-affinity phosphate transport in low phosphate environments65, 
66, and VTC4 and VTC1. 
Determination of changes in the transcriptome upon gene silencing is a powerful approach for 
functional characterization of genes67, 68. Profiles obtained with such approaches represent a fingerprint 
of the effects a gene has on cellular physiology69. For a multifunctional protein, genome-wide expression 
profiles of the deletion mutant should reflect the different cellular pathways affected by the absence of 
the respective gene/protein. The set of 67 identified genes that change their expression in response to 
the absence of Izh2 more than 2-fold under conditions of zinc depletion overlaps significantly (29 genes; 
hypergeometric distribution p=3.68 × 10-27) with the 185 genes that have been found as differentially 
expressed in zap1Δ cells shifted to low zinc environment70.  Less significant overlap (21 genes; p=1.1 × 
10-3) exists with the 1001 differentially expressed genes of cells which have been for 6 hours depleted 
for H4 histone71. This suggests that some genes that are regulated by a decrease in zinc concentration, 
but not by Zap1, are under the control of Izh2, and indicate that the effect of Izh2 on gene expression is 
perhaps at least partly the result of chromatin modification/remodeling. Based on this expression 
patterns comparison we compiled a set of genes whose expression is changed upon decreased zinc 
concentration and apparently activated by Izh2, but not by Zap1 – these genes are CLB1, ENB1, FIT1, 
MET6, SAG1, SRP101, TPA1 and TSR1. Products of two of these, FIT1 and ENB1, are involved in the 
maintenance of iron homeostasis. 
 
The relationship between Ino1/inositol and Zap1 
Following the identification in the chemogenomic screening of the ino1Δ strain as being resistant to zinc 
depletion and in addition INO1 gene expression being affected by Izh2, we analyzed in more detail the 
requirement for inositol under conditions of zinc depletion. We used liquid media without inositol, with 
2 mg/mL (i.e. normal yeast medium concentration) or 20 mg/mL of inositol (excess inositol), with either 
50 nM (depletion) or 2.5 µM (control) zinc concentrations, and determined the growth rates of the wild-
type, ino1Δ and zap1Δ strains. To minimize the effect of residual Zn and inositol in the cells, pre-cultures 
were grown in medium with 2 mg/mL inositol and 50 nM Zn. Reference strain cells grew slower in media 
with lower inositol concentrations under zinc depletion, but were not affected by the lack of inositol 
under normal zinc conditions (Figure 3A-B). These results suggest that adaptation to low zinc 
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concentrations requires higher amounts of inositol, and/or that cellular adaptation to decreased levels 
of zinc hinders inositol biosynthesis. The former notion is supported by faster growth of all three tested 
strains with elevated 20 mg/mL inositol concentrations under zinc depletion (Figure 3C). The latter 
notion could be caused by inhibition of Ino1, the key enzyme in inositol biosynthesis, under zinc 
depletion, in agreement with the findings that under such conditions Opi1 is released from the 
membrane and translocated into the nucleus7. Consistent with this possibility, we observed a small 
relative decrease in the growth rate of ino1Δ cells grown in depleted zinc in the presence of 2 mg/mL 
inositol, compared to that of the reference strain. Interestingly, we observed a partial rescue of ino1Δ 
cells in medium lacking inositol by zinc depletion. We assume that this occurs because of elevated PI 
content under low zinc conditions, caused by Zap1 activity and PI being an important source of inositol 
even in cells with active Ino17, 72. Growth of zap1Δ cells, as expected, was decreased at low Zn 
concentrations, and additional inositol depletion significantly potentiated this trend (Figure 3). This 
result is in line with the assumption that PI serves as a source of inositol, as well as with the possibility of 
Zap1 being involved in the regulation of INO1 gene expression, possibly indirectly through altered PI 
levels and Opi1 activation72. 
 
The role of the Zrt1 transporter 
Given the fact that expression of ZRT1 has been reported to be regulated by Rim10173, in addition to 
regulation by Zap12723, and according to our data also by Izh2 (see above), we investigated in more detail 
the role of Zrt1 in the increased resistance of Rim101 pathway component deletion strains to elevated 
environmental zinc concentrations. Protein abundance of Zrt1-GFP was measured in rim101Δ, rim8Δ 
and the corresponding wild type reference strain under normal zinc concentrations, at elevated zinc 
concentrations (2 mM; Figure 4A), or after the treatment with the EDTA chelator causing zinc depletion 
(Figure 4B). We found elevated levels of Zrt1 in the Rim101 pathway mutants under normal zinc 
conditions, in agreement with the findings from Hu and coworkers73, and also under elevated zinc 
conditions (Figure 4A). Rapid increase of Zrt1 expression occurs upon zinc depletion with EDTA, and this 
process is unaffected in the mutants of the Rim101 pathway (Figure 4B). The latter effect was also 
followed on ZRT1 gene expression level by Northern blot. We observed a slight, but reproducible and 
significant increase in ZRT1 mRNA accumulation under normal growth conditions in the Rim101 pathway 
mutants, consistent with the increase in Zrt1-GFP observed under the same conditions, and a strong 
increase of ZRT1 mRNA accumulation upon EDTA treatment in all three strains, but more rapidly in 
rim101Δ (Figure 4C). The relative amount and subcellular localization of Zrt1-GFP was also determined in 
the three strains under the same experimental conditions by confocal microscopy. In all cases, the 
relative Zrt1-GFP abundance observed in the immunoblots was confirmed and Zrt1-GFP was always 
localized to the ER and the plasma membrane (data not shown), in agreement with previous reports 
(yeastgenome.org: YPL+, YeastGFP). 
The increased amount of Zrt1 cannot per se explain the resistance of the Rim101 pathway deficient 
mutants to elevated environmental zinc concentration. We reasoned that Rim101 pathway mutants 
might have for some reason lower intracellular zinc levels, despite higher expression of Zrt1. We 
therefore measured the intracellular zinc concentrations under normal and elevated environmental zinc 
levels in rim101Δ, rim8Δ, dfg16Δ, zrt1Δ, zap1Δ and the corresponding wild type reference strain. 
Contrary to our hypothesis, total intracellular zinc concentration in the Rim101 pathway mutants was 
indistinguishable from the reference wild type strain under normal environmental zinc, and, if anything, 
slightly increased when 4 mM ZnCl2 was added to the medium (Figure 5A&B). Very similar results were 
obtained also for the zrt1Δ strain, whereas in the zap1Δ strain intracellular zinc concentration was 
significantly lower in an environment with normal zinc concentrations, but slightly exceeded the wild 
type levels when 4 mM ZnCl2 was added to the medium (Figure 5A&B). Notably, as described previously, 
Rim101 pathway component deletion strains have increased resistance to zinc overload in the 
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environment, despite the fact that their total intracellular zinc concentrations are comparable to that of 
the wild type strain (Figure 5C). These findings therefore further suggest that active Rim101 pathway 
causes some cellular effects which decrease the resistance to zinc toxicity. 
 
Discussion 
Adaptation to extreme zinc concentrations is a complex cellular process that affects several biochemical 
pathways. The first line of adaptation has to provide adequate concentrations of zinc in the cytosol and 
this is achieved by increased uptake rate from the environment or release from the vacuole in case of 
zinc depletion, or sequestration in vacuoles in the case of excess cytosolic zinc2. We found in our 
screenings that the activity of Vph1, the subunit a of V-ATPase, is of critical importance for maintaining 
cytosolic zinc concentrations within the homeostatic limits, in agreement with and extending previous 
knowledge on the importance of the V-ATPase holoenzyme in maintaining zinc homeostasis38. We 
identified genetic interactions between IZH2 and STV1, which encodes the other isomer of subunit a of 
V-ATPase that is however found in the Golgi apparatus and in endosomes rather than on the vacuolar 
membrane like Vph152, and between IZH2 and RAV1, which encodes a subunit of the RAVE complex that 
facilitates assembly of the V-ATPase holoenzyme53, 54. These results indicate a functional link between 
Izh2 and the V-ATPase, which is most probably the consequence of the roles of V-ATPase and Izh2 in 
maintaining zinc homeostasis, as exemplified by the sensitivity of the izh2Δ strain to elevated zinc 
concentrations16, 55. 
A crucial part of cellular adaptation to decreased zinc levels is the response at the gene expression level, 
mostly mediated by the Zap1 transcriptional activator27. Our results demonstrated that Izh2 is also 
involved in the response to altered zinc availability at the level of gene expression regulation. We 
identified genes that are exclusively under the control of Izh2 and not Zap1, but we also observed some 
overlap between the activities of these two proteins. An example of the latter is expression of ZRT1 
gene, which is regulated by Zap1 when zinc is depleted27, whereas our experiments revealed that it is 
regulated by Izh2 under normal zinc concentrations. Moreover, we showed that Izh2 regulates the 
expression of three genes coding for three out of four known plasma membrane transporters of zinc: 
Izh2 activates the expression of ZRT1, encoding the major, high-affinity zinc transporter, and FET4, 
encoding a low-affinity iron transporter capable of transporting zinc ions, but inhibits the expression of 
PHO84, which codes for a high-affinity inorganic phosphate transporter that also can mediate transport 
of zinc. Only ZRT2, the low-affinity plasma membrane zinc transporter, which is regulated by Zap127, 74, 
was not found to be under control of Izh2. While this transcriptional regulation by Izh2 influences zinc 
homeostasis, it is also important for the homeostasis of iron and phosphate. Indeed, our transcriptomic 
analysis revealed that Izh2 regulates expression of genes encoding additional proteins involved in iron 
transport and inhibits inorganic phosphate uptake by inhibiting the expression of genes coding for acid 
phosphatases, phosphate transporters, proteins required for vacuolar polyphosphate accumulation, and 
a negative regulator of low-affinity phosphate transport. These results are in agreement with and 
extend the results of the study by Karpichev and co-workers15, wherein they showed that acid 
phosphatase activity is constitutively expressed in izh2Δ cells, leading to increased accumulation of 
polyphosphate in the mutant. 
Zinc homeostasis is closely linked to regulation of phospholipid metabolism7. Results of our study 
indicate that Izh2 is connected to the phospholipid metabolism through co-regulation of the expression 
of INO1 and CHO1 genes with Zap1, strengthening also the zinc-phospholipid metabolism homeostasis 
connection through inositol. Based on our results, biosynthesis of inositol through Ino1 may not be 
beneficial for growth at low zinc concentrations, as indicated by the relative resistance of ino1Δ cells to 
zinc depletion. On the other hand, inositol biosynthesis is very likely required at high zinc concentrations 
where the PI concentration cannot be increased through Zap1-mediated Pis1 and Dpp1 activation. 
Regulation of inositol biosynthesis is also tightly linked to intracellular pH control75. Because of extensive 
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chemogenetic interactions found in this study between zinc and the Rim101 pathway components, 
which relay information on increased pH, we investigated the role of this pathway in zinc homeostasis in 
more detail. The Rim101 pathway, however, was found to have alkaline pH-independent activity that is 
important for zinc homeostasis. This role of the Rim101 pathway could be connected to its role in alkali 
cation homeostasis76, 77, and/or be the consequence of Rim101 being a zinc-finger transcription factor. 
Interestingly, Rim101 represses the expression of the Nrg1 transcription factor48, which is negatively 
regulated also by Izh219. Since Rim101 also regulates ZRT1 expression73, we made a series of 
experiments to test whether a decrease of zinc import via Zrt1 is in any way involved in the increased 
resistance to zinc overload toxicity in the Rim101 pathway deficient mutants. All the obtained 
experimental data disputed this hypothesis, but rather provided evidence that Zrt1 responds to zinc 
depletion independently from the Rim101 pathway. Our results strongly suggest that the active Rim101 
pathway causes cellular effects which decrease the resistance to zinc toxicity. Further studies will be 
needed to address this question in more detail. 
Taken together, data obtained in this study indicate a multi-factorial fingerprint of Izh2. It has been 
known prior to our study that Izh2 plays a role in several different cellular processes, of which zinc 
homoeostasis has been deemed the most important, and that its activity is regulated by different input 
stimuli, including fatty acids and hypoxia16, 17. We have shown that even when a single input – change in 
zinc concentration – is used, Izh2 still affects several cellular processes. While for all of them a link to 
zinc homeostasis can be inferred, they do not necessarily affect cytosolic zinc concentrations. The 
results support the notion that the roles that Izh2 plays in yeast cells with sub- or super-optimal Zn 
concentrations are not exclusively directly linked to zinc homeostasis; actually, since Izh2 regulates 
expression of iron transporters and phosphatase activity, in addition to ZRT1 expression at normal zinc 
concentrations, it is possible that one of its roles is to maintain the physiological ratio between 
intracellular zinc, iron and phosphate. A recent study revealed a similar parallel action of the major iron-
regulated transcription factor, Aft1, and the Rim101 pathway78. 
Since different cellular perturbations, such as zinc content, lipid composition and hypoxia, influence the 
expression and activity of Izh2, and as a range of different cellular processes are apparently affected by 
Izh2, we propose that Izh2 functions as an integrator of intra- and extracellular signals in providing 
adequate cellular responses to maintain homeostasis under different perturbations. Izh2 is not the 
central regulator of zinc homeostasis like Zap1. It rather represents the second line of cellular 
adaptation to perturbations to zinc homeostasis, which complements the activity of Zap1, and, maybe 
even more importantly, ameliorates intracellular imbalances caused by the first line of adaptation 
whose primary aim is to retain a single parameter – zinc concentration in this case – within homeostatic 
boundaries. Izh2 thus affects a wide range of cellular processes, reflecting the multiple effects caused by 
changes in zinc concentration affecting the many zinc-dependent proteins. Perhaps rectifying 
intracellular imbalances caused by the first line of adaptation has also been the main evolutionary driver 
that led to multifunctionality, at least in the case of proteins involved in zinc homeostasis in yeast. For 
instance, Zap1-mediated regulation of INO1, indirectly through altered PI levels and Opi1 activation72, is 
an illustration of a strategy where pathway buffering minimizes the negative effects of the action of the 
first line of adaptation: low zinc requires activation of zinc transporters (e.g. Zrt1) with Zap1, but zinc 
depletion by many Zn-dependent proteins with important roles in lipid metabolism also modulates lipid 
homeostasis. Zap1 therefore evolved to activate expression of PIS1, CKI1 and EKI1, encoding key 
enzymes in phospholipid biosynthesis, thus co-regulating lipid metabolism. It is notable in this respect 
that lipid metabolism is strongly regulated at the epigenetic level79, which is, through Zn-dependent 
HDACs, heavily dependent on zinc concentration. A similar hierarchy of shared control between 
regulators has been proposed before, for instance in membrane alterations caused by ergosterol and 
heme depletion80. While Hog1 has been the multifunctional protein shown in that study to confer 
cellular adaptation, it is interesting that Izh2 has been linked with both ergosterol metabolism and 
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cellular response to hypoxia16, 55. Additional overlap between hypoxia and Izh2 has been revealed in a 
study that demonstrated how inositol supplementation affected the yeast transcriptome such that six 
distinct expression responses (i.e. sub-profiles) could be identified, one of them being regulated by 
Mga2 and consisting of lipid-remodeling genes, including IZH281. 
How does Izh2 influence gene expression? It has previously been shown that the signal transduction 
pathway downstream of Izh2 requires cAMP-dependent kinase and AMP-dependent kinase activities19. 
It has also been proposed that Izh2 influences the activity of Nrg1/Nrg2 and Msn2/Msn4 transcription 
factors19. In addition, the observed overlap of transcriptional profiles indicates that chromatin 
remodeling could be part of the Izh2-mediated signal transduction pathway. Genetic interactions found 
in this study between IZH2 and genes UME1 and IOC4 coding for proteins involved in chromatin 
remodeling support this hypothesis. Moreover, majority of yeast HDACs, including Rpd3, are Zn-
dependent. In our chemogenomic screening, deletions of five genes encoding components of the Rpd3L 
HDAC complex resulted in increased resistance to excess zinc. This is most likely a consequence of the 
modulation of Rpd3L complex activity by altered cytosolic zinc concentrations, which itself is regulated 
by Rpd3, creating a feed-back loop. Moreover, among its targets, Rpd3 has been shown to repress the 
expression of ZRT3, encoding a vacuolar transporter which releases zinc from the vacuole when this 
mineral is deficient82. Genetic and functional interactions between UME1 and IZH2 suggest that Izh2 
could play a role in the HDAC/Zn homeostasis cross-talk, in agreement with a previously published 
report24. A possible explanation for these results is that excess zinc, which is probably a rare stressful 
condition in natural environments of S. cerevisiae, strongly activates the Rpd3L HDAC complex. It will be 
interesting to test in the future if, through the inhibitory effect of Dep1 on INO1 and CHO1 expression42, 
and of Sin3 on OPI1 expression43, also increased zinc concentrations lead to inositol imbalance. Another 
link between inositol and HDACs has been revealed recently in a study which has shown that activity of 
class I HDACs, of which Rpd3 is a member, is regulated by inositol phosphates83. This finding opens the 
question of whether inositol biosynthesis is of central importance and highly regulated on the 
transcriptional level81 due to this regulatory role, rather than because of its structural role as a part of 
membrane lipids. In line with the former notion, another recent study demonstrated that Kcs1, a yeast 
inositol pyrophosphate kinase, controls INO1 transcription in an Opi1-independent manner, by 
regulating the synthesis of inositol pyrophosphates84. 
Izh2 is a homolog of AdipoR, which plays an important role in type 2 diabetes. Lipid metabolism and zinc 
homeostasis are unbalanced in type 2 diabetes, and the role of Izh2 in yeast elucidated here could help 
better understand also the role of AdipoR in human health and disease. Finally, it should be pointed out 
that three other IZH paralogs are present in the yeast genome, and that their role, which was not 
analyzed in the present study, should not be neglected, especially in the case of IZH4, which is similar to 
IZH2 in many aspects. Further studies will be required to reveal the concerted action of Izh1, Izh2, Izh3 
and Izh4 in maintaining zinc homeostasis and other biological processes that they affect. 
 
Materials and Methods 
Yeast strains, plasmids and media 
To test the effect of different zinc concentrations on a genome-wide scale, the yeast S. cerevisiae 
deletion collection (MATa his3Δ leu2Δ ura3Δ met15Δ yyy∆::kanMX) was used. Unless otherwise noted, 
individual strains from the same collection, as well as the corresponding reference strain (MATa leu2Δ 
ura3Δ met15Δ his3∆::kanMX) were used in other experiments as described. 
To integrate the GFP coding sequence at the C-terminus of ZRT1, the GFP::HIS3 module was amplified by 
PCR from the pFA6a-GFP(S65T)-HIS3MX6 vector85 using chimeric primers containing 20 bp 
corresponding to the GFP::HIS3 module and 45 bp corresponding to the ZRT1 sequence immediately 
upstream and downstream of the STOP codon required for correct recombination. Recombinants were 
confirmed by sequencing PCR products which were amplified from genomic DNA using a forward primer 
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50 bp upstream of the ZRT1 STOP codon and a reverse primer 100 bp downstream of the HIS3 start 
codon. 
Chelated Yeast Casamino Dextrose (CYCD) (0.5 % (w/v) yeast nitrogen base without amino acids, 
divalent ions and phosphate (MP Biomedicals, USA), 0.5 % (w/v) casamino acids (Difco, USA), 0.01 % 
(w/v) adenine (Serva, Germany), 0.01 % (w/v) uracil (Serva, Germany), 0.01 % (w/v) tryptophan (Fluka, 
Germany), 2 % (w/v) glucose (Fluka, Germany),  2 % (w/v) agar (Sigma-Aldrich, USA)) was used in 
experiments where the effect of zinc depletion was assessed. Zinc was removed from the medium by 
pretreatment with Chelex 100 resin (Sigma, USA) as per manufacturer's instructions. ZnCl2 was added to 
a final zinc concentration of 50 nM and 10 μM (2.5 μM for liquid media), for the zinc-depleted and 
control media, respectively. Other cations were added back to their original concentrations: 0.9 mM 
Ca2+, 0.25 μM Cu2+, 1.2 μM Fe3+, 7 mM K+, 4.1 mM Mg2+, 2.65 μM Mn2+. 
For growth curve analysis to assess the effect of zinc depletion and varying inositol concentrations on 
the ino1∆, zap1∆ and wild-type strains, CYCD-inositol (0.5 % (w/v)  yeast nitrogen base without amino 
acids and inositol (Formedium, UK), the rest as in CYCD) with inositol (Fluka, Switzerland) added to a 
final concentration of 20 mg/l (excess inositol concentration), 2 mg/l (control inositol concentration) or 0 
mg/l (no inositol) was used. 
To minimize the effect of vacuolar zinc storage on the results of all zinc depletion experiments, strains 
were first grown in Yeast Casamino Dextrose (YCD, prepared as CYCD with omitted chelation and 
addition of ions) before their transfer to zinc-deplete and control media. No intermediate media was 
used in the excess zinc experiments. 
For excess zinc chemogenomics, YPD (1 % (w/v) yeast extract (Sigma, USA), 2 % (w/v) peptone (Sigma, 
USA), 2 % (w/v) glucose (Fluka, Germany), 2 % (w/v) agar (Sigma-Aldrich, USA)) with 4 mM or with no 
added ZnCl2 was used in test and control media, respectively. 
Growth fitness of rim8∆, rim9∆, rim13∆, rim20∆, rim21∆, rim101∆, dfg16∆, ygr122w∆, stp22∆, vps20∆, 
vps25∆, vps28∆, vps36∆, vps37∆, snf7∆, snf8∆, and the wild-type strain was assessed in YPD media 
containing 2 mM ZnCl2, as well as control YPD media. Additionally, for growth curve analysis to test the 
combinatorial effects of pH and excess zinc, rim9∆, rim20∆, rim101∆, zap1∆, and the wild-type strain 
were grown in YPD media containing 150mM HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic 
acid; Serva, Germany) at pH 4 or 6 and a final 2 mM or 4 mM ZnCl2 concentration. No ZnCl2 was added in 
control media (buffered YPD). 
To construct the query strain for synthetic genetic array (SGA) analysis, primers IZH2_up ( 
GTTCCTTGAGCCAAATGTACTAAATTTCCCGTCGTTTTAATTATGAGCTTGCCTTGTCCCCGCCG) and 
IZH2_dn (TAAAACTACTTTCTATATAAATCCTACGTTTTTTCCAAATATCTATCGACACTGGATGGCGGCGT) were 
used to replace the IZH2 gene of the parental strain AJY217 (S288c derivative; MATα his3Δ leu2Δ ura3Δ 




To identify deletion strains sensitive to altered zinc concentrations (zinc-deplete or excess zinc 
conditions), plates from the yeast deletion collection were first pinned on test plates and then 
sequentially on control plates. To identify deletion strains resistant to altered zinc concentrations, plates 
were first pinned on control plates and then sequentially on test plates. Plates were incubated at 30°C 
for 48h (control plates of excess zinc screen), 72h (test plates in test-to-control direction of excess zinc 
screen; control plates of zinc-depletion screen), 96h (test plates of zinc-depletion screen, test plates in 
control-to-test direction of excess zinc screen). For both conditions the screen was done in triplicate. 
The relative growth fitness was determined as described in Mattiazzi et al.86. Higher confidence 
chemogenomic interactors were defined as those with relative growth fitness lower than (mean -2 
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standard deviations (SD)), while lower confidence interactors were defined as those with relative growth 
fitness between (mean -1SD) and (mean -2SD). 
 
SGA analysis of the IZH2 gene 
SGA analysis was carried out as described in Tong et al.51. For the identification of IZH2 genetic 
interactors in altered zinc conditions, the obtained double mutants were pinned on zinc-depleted and 
excess zinc media as well as on corresponding control plates. The relative growth fitness of double 
mutants was calculated as described in Mattiazzi et al.86. Genetic interactors were identified as those 
that had relative growth fitness across biological replicates statistically significantly different (p-value < 
0.05) from the average relative growth fitness of all strains. 
 
Growth curve analysis 
Growth curve measurements were done as described in Mattiazzi et al.86. Strains and media used are 
described above, with the exception of the reference strain where BY4741 strain was used. 
 
Transcriptome analysis 
DNA microarrays were used to determine the effect of the IZH2 gene deletion on the yeast 
transcriptome. Gene expression in izh2Δ strain was compared to that of the control wild-type strain 
under zinc deplete (50 nM ZnCl2) as well as under optimal zinc conditions (10 μM ZnCl2). 
Microarray post-processing, RNA sample preparation, cDNA synthesis, labeling, and DNA microarray 
hybridizations followed published procedures87, with some modifications. For cDNA synthesis in the 
presence of amino-allyl dUTP 2μg mRNA were used. The test cDNA sample (izh2Δ strain) was labeled 
with Cy5 and the control sample (wild-type strain) with Cy3 fluorescent dye. For cleanup of cDNA 
synthesis and dye-coupling reactions QIAquick PCR purification kit (Qiagen, Chatsworth, CA, USA) was 
used. Microarray hybridizations were incubated at 65°C for 16 h. Microarrays were scanned with 
GenePix Personal 4100A microarray scanner (Axon Instruments, Union City, CA, USA) and analyzed using 
GenePix Pro 6.0 software (Axon Instruments). Cy5 and Cy3 median intensities were background-
corrected and normalized using a regression correlation (NOMAD; http://ucsf-nomad.sourceforge.net/). 
Data was furher background-corrected and normalized using Bioconductor limma package88, functions 
backgroundCorrect(method="normexp", offset=50), normalizeWithinArrays and 
normalizeBetweenArrays(method="Aquantile"). Differentially expressed genes were determined using 
Bioconductor limma package88, functions lmFit and eBayes with default parameters. In Supplementary 
Table 3, we report p-values and FDR adjusted estimates for top 8000 differentially expressed genes 
(limma function toptable(number=8000, adjust=”FDR”)). We tested for differential expression between 
wild-type and izh2Δ deletion strain under zinc depletion and optimal zinc conditions, respectively (one 
replicate for each condition). This resulted in two lists of differentially expressed genes, one for each 
condition, which were used to investigate the specific function of Izh2 under the two conditions.  To 
assess the role of Izh2 globally, microarray data from normal and limiting zinc were combined, and 
differential expression analysis was performed between the deletion strain and the wild-type. 
All DNA microarray data is available from the ArrayExpress database (accession number: E-MEXP-3995). 
 
Preparation of protein extracts 
For Zrt1 induction, the indicated stains were grown to log-phase in YPD media and treated with EDTA 
(final concentration 1 mM) for the indicated times. To prepare whole cell extracts, 3 mL of cells were 
collected by centrifugation and the cell pellet was resuspended in 50 µL of Laemmli sample buffer89 and 
heated for 5 minutes at 95oC. For treatment with ZnCl2, the indicated yeast strains were grown in 
minimal medium to mid-log phase. Cells were incubated for the indicated times in medium with or 
without ZnCl2 (final concentration 2 mM), harvested by centrifugation, resuspended in homogenization 
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buffer (50 mM Tris [pH 7,6], 0.1 M KCl, 5 mM EDTA, 5 mM dithioerythritol, 20% [wt/vol] sucrose, 
protease inhibitor cocktail [Roche]) and lysed by vortexing with glass beads. The lysate was centrifuged 
for 5 min at 500 g to remove insoluble material. The crude extract was separated into soluble and 
particulate fractions by centrifugation for 30 min at 16,000 g at 4°C. The particulate fraction was 
resuspended directly in Laemmli sample buffer. 
 
Immunoblots 
Proteins were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, transferred to 
nitrocellulose membranes, and immunoblotted with a monoclonal anti-GFP antibody (Roche Diagnostics 
GmbH, Mannheim, Germany). Immunoreactive bands were visualized using the ECL-Plus 
chemiluminescence system and horseradish peroxidase-conjugated secondary antibodies (Amersham 
Biosciences UK Ltd., England).  Western blots were quantified using the Image Gauge software v. 4.0. 
Zrt1-GFP signals were normalized using the Direct Blue 71 (Sigma) staining of the membrane. 
 
Preparation of Yeast RNA 
The indicated strains were grown in YPD medium to mid-log phase and treated with EDTA (final 
concentration 1 mM) for the indicated times. One hundred mL of cells were harvested by centrifugation. 
Cell pellets were resuspended in 150 µL TCES buffer (0.2 M NaCl, 0.2 M Tris-HCl [pH 8], 0.05 M EDTA, 
sodium dodecyl sulfate 2%) and 500 µL of glass beads (0.45-0.50 mm diameter) were added to the cell 
suspension. Immediately following addition of 150 µL of phenol/chloroform/isoamyl alcohol mixture 
(25:24:1 [v/v/v]), cells were broken by vigorous vortexing. After addition of 200 μL TCES buffer and a 
brief centrifugation, the supernatant was transferred to a fresh tube and one volume of 
chloroform/isoamyl alcohol (24/1) was added. After vortexing, the mixture was centrifuged for 3 
minutes. The RNA contained in the upper phase was precipitated by adding 2 volumes of ethanol, 
collected by centrifugation, washed with 70% ethanol, dried and resuspended in 30 µL of sterile Milli-Q 
water. 
 
Northern blot analysis 
Twenty μg of RNA per lane were separated in formaldehyde gels and blotted onto nylon membranes 
(Hybond-N, Amersham). Probes containing PCR-derived fragments of GFP (bp 43-490) or ACT1 (bp 518-
1182) were radioactively labeled using the High Prime kit (Roche, France) following manufacturer’s 
instructions. Radioactively labeled probes were hybridized in PSE buffer (300 mM NaH2PO4/Na2HPO4 pH 
7.2, 7% SDS, 1 mM EDTA) for 12 hours at 65oC. Membranes were washed twice with 4x SSC/0.1% SDS 
and once with 0.4x SSC/0.1% SDS for 10 minutes at 65oC. Signals were quantified using a Fujifilm BAS-
1500 phosphoimager. Data are expressed as the ratio of GFP/ACT1 signal in each strain and condition. 
 
Intracellular zinc concentration measurements 
Intracellular zinc concentrations were determined by flame atomic absorption spectrometry on a Varian 
SpectrAA 110 spectrometer (Mulgrove, Victoria, Australia) in rim101Δ, rim8Δ, dfg16Δ, zrt1Δ, zap1Δ and 
corresponding wild type reference (BY4741) strains. The cultures were grown in YPD (pH 5.4) media 
under normal and elevated environmental zinc levels (4 mM) from the initial OD600 of approximately 0.2 
till OD600 of 0.8-1.0. Cells (100 mL of culture) were then collected by centrifugation, washed twice with 
10 mL cold 1 mM EDTA, once with 10 mL cold miliQ, flash frozen in liquid nitrogen and stored at -80°C.  
For intracellular zinc measurements the collected cells were digested in a mixture of 200 μL 30 % H2O2 
and 200 μL 65 % HNO3 for approximately 42 h at 80°C to obtain a clear solution. Before determination by 
FASS samples were diluted with miliQ water to 50 mL. 
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Figure 1: Growth curves under conditions of different pH and elevated zinc levels of selected strains. 
A-C) Growth curves of mutants in the Rim101 pathway components at elevated Zn concentrations (2 
mM and 4 mM) at pH 4 and pH 6. The control Zn concentration was 2.5 µM. D) Growth curves of the 
zap1Δ mutant at elevated Zn concentrations (2 mM and 4 mM) at pH 4 and pH 6. The control Zn 
concentration was 2.5 µM. WT – reference strain. 
 
Figure 2: Numbers of genes identified in IZH2 genetic interaction screens and their overlap with Zn 
chemogenomic screens. A) Number of genes in genetic interaction with IZH2 at different Zn 
concentrations: Zn depletion – 50 nM, normal Zn – 10 µM, Zn overload – 4 mM. B) Overlap of genes in 
genetic interaction with IZH2 and genes whose mutations render the yeast cell sensitive or resistant to 
depleted (50 nM) or excess (4 mM) zinc. 
 
Figure 3: Growth curves of reference strain, zap1Δ and ino1Δ cells at different inositol and zinc 
concentrations. A) No inositol in the medium. B) Concentration of inositol in the medium 2 mg/mL. B) 
Concentration of inositol in the medium 20 mg/mL.  D – depleted Zn (50 nM); C – control Zn 
concentration (2.5 µM); WT – reference strain. 
 
Figure 4: Zrt1 protein and mRNA expression levels in Rim101 pathway mutants. A) Zrt1 protein levels 
in response to zinc overload (final concentration 2 mM ZnCl2). B) Zrt1 protein levels in response to zinc 
depletion. Strains were treated for the indicated time (in hours) with 1 mM EDTA. In both cases the 
amount of Zrt1-GFP protein was analyzed by immunoblotting using a specific GFP antibody. Direct Blue 
staining of the membrane is shown in the lower panels as a loading control with relative intensity of the 
normalized signal indicated below each lane. Similar results were observed for 2 independent 
transformants. C) Zrt1 mRNA levels in response to zinc depletion. The amount of ZRT1-GFP transcript 
was analyzed by northern blot using a specific GFP probe. The ACT1 gene was used to normalize ZRT1 
expression levels. Data are expressed in arbitrary units. Shown are average values and standard 
deviations of 3 independent replicates. * p-value < 0.05. WT – reference strain. 
 
Figure 5: Flame atomic absorption spectrometry analysis of total intracellular zinc concentrations. A) 
Cells were grown in rich (YPD) medium under normal extracellular zinc concentration (10 μM). B) Cells 
were grown in rich (YPD) medium under elevated extracellular zinc concentration (4 mM). C) Ratio of 
intracellular zinc concentration between cells grown under elevated and normal extracellular zinc 
concentrations. Error bars represent standard deviation from two independent measurements. *** p-
value < 0.001, ** p-value < 0.01. WT – reference strain. 
 
































































Growth curves under conditions of different pH and elevated zinc levels of selected strains. A-C) 
Growth curves of mutants in the Rim101 pathway components at elevated Zn concentrations (2 mM and 4 
mM) at pH 4 and pH 6. The control Zn concentration was 2.5 µM. D) Growth curves of the zap1∆ mutant at 
elevated Zn concentrations (2 mM and 4 mM) at pH 4 and pH 6. The control Zn concentration was 2.5 µM. 
WT – reference strain.  
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Numbers of genes identified in IZH2 genetic interaction screens and their overlap with Zn 
chemogenomic screens. A) Number of genes in genetic interaction with IZH2 at different Zn 
concentrations: Zn depletion – 50 nM, normal Zn – 10 µM, Zn overload – 4 mM. B) Overlap of genes in 
genetic interaction with IZH2 and genes whose mutations render the yeast cell sensitive or resistant to 
depleted (50 nM) or excess (4 mM) zinc.  
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Growth curves of reference strain, zap1∆ and ino1∆ cells at different inositol and zinc 
concentrations. A) No inositol in the medium. B) Concentration of inositol in the medium 2 mg/mL. B) 
Concentration of inositol in the medium 20 mg/mL.  D – depleted Zn (50 nM); C – control Zn concentration 
(2.5 µM); WT – reference strain.  
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Zrt1 protein and mRNA expression levels in Rim101 pathway mutants. A) Zrt1 protein levels in 
response to zinc overload (final concentration 2 mM ZnCl2). B) Zrt1 protein levels in response to zinc 
depletion. Strains were treated for the indicated time (in hours) with 1 mM EDTA. In both cases the amount 
of Zrt1-GFP protein was analyzed by immunoblotting using a specific GFP antibody. Direct Blue staining of 
the membrane is shown in the lower panels as a loading control with relative intensity of the normalized 
signal indicated below each lane. Similar results were observed for 2 independent transformants. C) Zrt1 
mRNA levels in response to zinc depletion. The amount of ZRT1-GFP transcript was analyzed by northern 
blot using a specific GFP probe. The ACT1 gene was used to normalize ZRT1 expression levels. Data are 
expressed in arbitrary units. Shown are average values and standard deviations of 3 independent replicates. 
* p-value < 0.05. WT – reference strain.  
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Flame atomic absorption spectrometry analysis of total intracellular zinc concentrations. A) Cells 
were grown in rich (YPD) medium under normal extracellular zinc concentration (10 µM). B) Cells were 
grown in rich (YPD) medium under elevated extracellular zinc concentration (4 mM). C) Ratio of intracellular 
zinc concentration between cells grown under elevated and normal extracellular zinc concentrations. Error 
bars represent standard deviation from two independent measurements. *** p-value < 0.001, ** p-value < 
0.01. WT – reference strain.  
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